Skip to main content
Erschienen in: Pituitary 5/2018

14.07.2018

Isolated adrenocorticotropic hormone deficiency as a form of paraneoplastic syndrome

verfasst von: Hironori Bando, Genzo Iguchi, Keitaro Kanie, Hitoshi Nishizawa, Ryusaku Matsumoto, Yasunori Fujita, Yukiko Odake, Kenichi Yoshida, Kentaro Suda, Hidenori Fukuoka, Keiko Tanaka, Wataru Ogawa, Yutaka Takahashi

Erschienen in: Pituitary | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In isolated adrenocorticoropic hormone (ACTH) deficiency (IAD), autoimmunity against corticotrophs has been suggested; however, the pathogenesis remains largely unknown. Large cell neuroendocrine carcinoma (LCNEC) of the lung is a pulmonary tumor of high-grade malignant neuroendocrine tumor and it reportedly caused paraneoplastic syndrome by autoimmunity in several cases.

Methods

A 42-year-old woman with isolated adrenocorticotropic (ACTH) hormone deficiency (IAD) was diagnosed with large cell neuroendocrine carcinoma (LCNEC) 3 years after being diagnosed with IAD. We hypothesized that the LCNEC played a causal role in the development of IAD as a paraneoplastic syndrome and analyzed the autoimmunity. We also analyzed another case of ectopic ACTH syndrome to prove this hypothesis.

Results

The LCNEC tissue revealed an ectopic ACTH expression and lymphocyte infiltration. Interestingly, autoantibody against the proopiomelanocortin (POMC) protein was detected in the peripheral blood. Although, patient’s serum did not show any effects on cell viability, proliferation, nor pomc expression in a corticotroph cell line, AtT20 cells, patient’s lymphocytes in the peripheral blood specifically reacted toward POMC protein, indicating a presence of cytotoxic T lymphocytes (CTLs). In addition, the analysis of another case of ectopic ACTH syndrome showed lymphocyte infiltration not only in the metastatic liver tumors but also in the pituitary. Moreover, most CD8-positive cells resided adjacent to corticotrophs.

Conclusions

These data indicate that the ectopic ACTH expression in the tumor evoked the autoimmunity to corticotrophs and caused IAD as a form of paraneoplastic syndrome.
Literatur
2.
Zurück zum Zitat Sauter NP, Toni R, McLaughlin CD, Dyess EM, Kritzman J, Lechan RM (1990) Isolated adrenocorticotropin deficiency associated with an autoantibody to a corticotroph antigen that is not adrenocorticotropin or other proopiomelanocortin-derived peptides. J Clin Endocrinol Metab 70(5):1391–1397. https://doi.org/10.1210/jcem-70-5-1391 CrossRefPubMed Sauter NP, Toni R, McLaughlin CD, Dyess EM, Kritzman J, Lechan RM (1990) Isolated adrenocorticotropin deficiency associated with an autoantibody to a corticotroph antigen that is not adrenocorticotropin or other proopiomelanocortin-derived peptides. J Clin Endocrinol Metab 70(5):1391–1397. https://​doi.​org/​10.​1210/​jcem-70-5-1391 CrossRefPubMed
4.
Zurück zum Zitat Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB Jr, Nieman L, Chrousos G, Pass H, Doppman J (1991) Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 15(6):529–553CrossRefPubMed Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB Jr, Nieman L, Chrousos G, Pass H, Doppman J (1991) Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 15(6):529–553CrossRefPubMed
7.
Zurück zum Zitat Stanford MR, Edelsten CE, Hughes JD, Sanders MD, Brooks CI, Mitchell D, Sheppard MN (1995) Paraneoplastic retinopathy in association with large cell neuroendocrine bronchial carcinoma. Br J Ophthalmol 79(6):617–618CrossRefPubMedPubMedCentral Stanford MR, Edelsten CE, Hughes JD, Sanders MD, Brooks CI, Mitchell D, Sheppard MN (1995) Paraneoplastic retinopathy in association with large cell neuroendocrine bronchial carcinoma. Br J Ophthalmol 79(6):617–618CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Kotani R, Nagata M, Moriyama H, Nakayama M, Yamada K, Chowdhury SA, Chakrabarty S, Jin Z, Yasuda H, Yokono K (2002) Detection of GAD65-reactive T-Cells in type 1 diabetes by immunoglobulin-free ELISPOT assays. Diabet Care 25(8):1390–1397CrossRef Kotani R, Nagata M, Moriyama H, Nakayama M, Yamada K, Chowdhury SA, Chakrabarty S, Jin Z, Yasuda H, Yokono K (2002) Detection of GAD65-reactive T-Cells in type 1 diabetes by immunoglobulin-free ELISPOT assays. Diabet Care 25(8):1390–1397CrossRef
10.
Zurück zum Zitat Bando H, Iguchi G, Fukuoka H, Yamamoto M, Hidaka-Takeno R, Okimura Y, Matsumoto R, Suda K, Nishizawa H, Takahashi M, Tojo K, Takahashi Y (2014) Involvement of PIT-1-reactive cytotoxic T lymphocytes in anti-PIT-1 antibody syndrome. J Clin Endocrinol Metab 99(9):E1744–E1749. https://doi.org/10.1210/jc.2014-1769 CrossRefPubMed Bando H, Iguchi G, Fukuoka H, Yamamoto M, Hidaka-Takeno R, Okimura Y, Matsumoto R, Suda K, Nishizawa H, Takahashi M, Tojo K, Takahashi Y (2014) Involvement of PIT-1-reactive cytotoxic T lymphocytes in anti-PIT-1 antibody syndrome. J Clin Endocrinol Metab 99(9):E1744–E1749. https://​doi.​org/​10.​1210/​jc.​2014-1769 CrossRefPubMed
13.
Zurück zum Zitat Yamaguchi H, Nakamura H, Mamiya Y, Yamamoto Y, Tajika K, Sugihara H, Gomi S, Inokuchi K, Hasegawa S, Shibazaki T, Dan K, Wakabayashi I (1997) Acute lymphoblastic leukemia with isolated adrenocorticotropic hormone deficiency. Intern Med 36(11):819–821CrossRefPubMed Yamaguchi H, Nakamura H, Mamiya Y, Yamamoto Y, Tajika K, Sugihara H, Gomi S, Inokuchi K, Hasegawa S, Shibazaki T, Dan K, Wakabayashi I (1997) Acute lymphoblastic leukemia with isolated adrenocorticotropic hormone deficiency. Intern Med 36(11):819–821CrossRefPubMed
16.
Zurück zum Zitat Alamowitch S, Graus F, Uchuya M, Rene R, Bescansa E, Delattre JY (1997) Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain 120(Pt 6):923–928CrossRefPubMed Alamowitch S, Graus F, Uchuya M, Rene R, Bescansa E, Delattre JY (1997) Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain 120(Pt 6):923–928CrossRefPubMed
18.
Zurück zum Zitat Maeda A, Ohguro H, Nabeta Y, Hirohashi Y, Sahara H, Maeda T, Wada Y, Sato T, Yun C, Nishimura Y, Torigoe T, Kuroki Y, Sato N (2001) Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome. Eur J Immunol 31(2):563–572CrossRefPubMed Maeda A, Ohguro H, Nabeta Y, Hirohashi Y, Sahara H, Maeda T, Wada Y, Sato T, Yun C, Nishimura Y, Torigoe T, Kuroki Y, Sato N (2001) Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome. Eur J Immunol 31(2):563–572CrossRefPubMed
19.
Zurück zum Zitat Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, Henson J, Posner JB, Furneaux HM (1991) HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67(2):325–333CrossRefPubMed Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, Henson J, Posner JB, Furneaux HM (1991) HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67(2):325–333CrossRefPubMed
20.
Zurück zum Zitat Tanaka M, Tanaka K, Shinozawa K, Idezuka J, Tsuji S (1998) Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. J Neurol Sci 161(1):88–90CrossRefPubMed Tanaka M, Tanaka K, Shinozawa K, Idezuka J, Tsuji S (1998) Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. J Neurol Sci 161(1):88–90CrossRefPubMed
21.
Zurück zum Zitat Tanaka K, Tanaka M, Inuzuka T, Nakano R, Tsuji S (1999) Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody. J Neurol Sci 163(2):159–162CrossRefPubMed Tanaka K, Tanaka M, Inuzuka T, Nakano R, Tsuji S (1999) Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody. J Neurol Sci 163(2):159–162CrossRefPubMed
22.
Zurück zum Zitat Kubo S, Kitamura O, Orihara Y, Tsuda R, Hirose W, Nakasono I (1997) Isolated adrenocorticotropic hormone deficiency: an autopsy case of adrenal crisis. A case report. Am J Forensic Med Pathol 18(2):202–205CrossRefPubMed Kubo S, Kitamura O, Orihara Y, Tsuda R, Hirose W, Nakasono I (1997) Isolated adrenocorticotropic hormone deficiency: an autopsy case of adrenal crisis. A case report. Am J Forensic Med Pathol 18(2):202–205CrossRefPubMed
23.
Zurück zum Zitat Richtsmeier AJ, Henry RA, Bloodworth JM Jr, Ehrlich EN (1980) Lymphoid hypophysitis with selective adrenocorticotropic hormone deficiency. Arch Intern Med 140(9):1243–1245CrossRefPubMed Richtsmeier AJ, Henry RA, Bloodworth JM Jr, Ehrlich EN (1980) Lymphoid hypophysitis with selective adrenocorticotropic hormone deficiency. Arch Intern Med 140(9):1243–1245CrossRefPubMed
26.
Zurück zum Zitat Rojas I, Graus F, Keime-Guibert F, Rene R, Delattre JY, Ramon JM, Dalmau J, Posner JB (2000) Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 55(5):713–715CrossRefPubMed Rojas I, Graus F, Keime-Guibert F, Rene R, Delattre JY, Ramon JM, Dalmau J, Posner JB (2000) Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 55(5):713–715CrossRefPubMed
Metadaten
Titel
Isolated adrenocorticotropic hormone deficiency as a form of paraneoplastic syndrome
verfasst von
Hironori Bando
Genzo Iguchi
Keitaro Kanie
Hitoshi Nishizawa
Ryusaku Matsumoto
Yasunori Fujita
Yukiko Odake
Kenichi Yoshida
Kentaro Suda
Hidenori Fukuoka
Keiko Tanaka
Wataru Ogawa
Yutaka Takahashi
Publikationsdatum
14.07.2018
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 5/2018
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-018-0901-7

Weitere Artikel der Ausgabe 5/2018

Pituitary 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.